About RevBio
RevBio is a company based in Lowell (United States) founded in 2014 by Michael Brown, Brian Hess, Jonathan Slotkin, George Kay, and Grayson Allen.. RevBio has raised $24.42 million across 16 funding rounds from investors including NIH, Pacific Dental Services and HHS. RevBio offers products and services including TETRANITE. RevBio operates in a competitive market with competitors including SINTX, MiMedx Group, Ossio, Theradaptive and EpiBone, among others.
- Headquarter Lowell, United States
- Founders Michael Brown, Brian Hess, Jonathan Slotkin, George Kay, Grayson Allen
-
Sectors
HealthcareChemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Revbio Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.42 M (USD)
in 16 rounds
-
Latest Funding Round
$1.7 M (USD), Grant
Sep 01, 2024
-
Investors
NIH
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RevBio
RevBio offers a comprehensive portfolio of products and services, including TETRANITE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Synthetic adhesive for bone repair and fixation in medical procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of RevBio
RevBio has successfully raised a total of $24.42M across 16 strategic funding rounds. The most recent funding activity was a Grant round of $1.7 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Grant — $1.7M
-
First Round
First Round
(28 Oct 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Grant - RevBio | Valuation |
investors |
|
| Oct, 2023 | Amount | Grant - RevBio | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - RevBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RevBio
RevBio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Pacific Dental Services and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RevBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RevBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Revbio Comparisons
Competitors of RevBio
RevBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SINTX, MiMedx Group, Ossio, Theradaptive and EpiBone, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Silicon nitride medical devices are manufactured for interbody fusion.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
|
| domain | founded_year | HQ Location |
Synthetic calcium composites are developed for bone repair and regeneration.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Revbio
Frequently Asked Questions about RevBio
When was RevBio founded?
RevBio was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is RevBio located?
RevBio is headquartered in Lowell, United States. It is registered at Lowell, Massachusetts, United States.
Who is the current CEO of RevBio?
Brian Hess is the current CEO of RevBio. They have also founded this company.
Is RevBio a funded company?
RevBio is a funded company, having raised a total of $24.42M across 16 funding rounds to date. The company's 1st funding round was a Grant of $2.99M, raised on Oct 28, 2015.
What does RevBio do?
RevBio was founded in 2014 in Lowell, United States, within the biotechnology sector. Synthetic adhesives for bone and dental repair are developed using proprietary Tetranite technology, a bio-engineered protein derived from worms. Applications include implant stabilization, fracture repair, spine fusion, dental bone grafting, joint reconstruction, and cranial flap fixation, with operations centered on advancing these medical solutions.
Who are the top competitors of RevBio?
RevBio's top competitors include EpiBone, Theradaptive and MiMedx Group.
What products or services does RevBio offer?
RevBio offers TETRANITE.
Who are RevBio's investors?
RevBio has 5 investors. Key investors include NIH, Pacific Dental Services, HHS, University of Pittsburgh, and MassChallenge.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.